Rocket Lab USA Inc. (RKLB) is poised to enter the Nasdaq-100 Index when U.S. markets reopen on Monday, a milestone that grants the space systems company greater exposure among growth-oriented portfolios. The move follows a holiday-shortened week that saw Rocket Lab shares climb approximately 4.7% to $107.24, though the stock remains nearly 29% below its late-May intraday peak of $151.
Index Inclusion Details
Nasdaq confirmed that Rocket Lab, along with Astera Labs, CoreWeave, Nebius, and Teradyne, will be added to the benchmark index before trading begins on June 22. The timing is notable: U.S. markets were closed Friday for Juneteenth and remain shut Sunday, meaning traders will react to the index change when Nasdaq opens at 9:30 a.m. EDT Monday. Rocket Lab ended Thursday's session at $107.24, down 0.69% for the day, with shares trading between $100.96 and $109.55 on volume of about 70.3 million shares.
Joining the Nasdaq-100 does not directly alter Rocket Lab's revenue stream, but it reshapes the investor base. The index is tracked by hundreds of investment products, including ETFs and mutual funds that replicate its composition. Nasdaq reports that over 200 investment vehicles track the Nasdaq-100, with combined assets exceeding $800 billion. This passive buying could provide a steady source of demand for Rocket Lab shares in the near term.
Market Context and Sector Volatility
Rocket Lab's ascent comes amid ongoing turbulence in the space sector, largely driven by the public market debut of SpaceX. SpaceX shares fell more than 6% on Thursday, paring gains from their first-day rally, and the decline rippled across the industry. Rocket Lab and Planet Labs each lost about 3%, while AST SpaceMobile dropped roughly 7%. IPOX Schuster analyst Kat Liu attributed the pullback to profit-taking, calling it "not surprising" after SpaceX's strong IPO performance.
However, KeyBanc analyst Michael Leshock pushed back against the negative read-across, describing the sector-wide slide as "unwarranted." In a report covered by MarketWatch, Leshock argued that the same catalysts boosting space stocks—including increased launch demand and government contracts—"have only accelerated." He upgraded Rocket Lab to overweight, highlighting the upcoming Neutron rocket as a key catalyst.
Execution and Financial Performance
Execution remains the central question for Rocket Lab investors. The company reported first-quarter revenue of $200.3 million, a 63.5% year-over-year increase, and its backlog reached a record $2.2 billion. CEO Sir Peter Beck described the Nasdaq-100 listing as a "landmark moment" and emphasized the company's placement alongside "some of the world's most innovative companies." Since going public in 2021, Rocket Lab has completed over 80 successful launches and deployed more than 250 satellites.
Beck has also pointed to "strong tailwinds" in the business, citing demand for launch services, hypersonic testing, and national security missions. The Neutron rocket, a medium-lift vehicle under development, is a focal point for investors. But the company has cautioned that timelines for Neutron, launch schedules, and broader strategy remain subject to risks and forward-looking uncertainties.
Outlook and Analyst Views
While index inclusion could provide a temporary lift, some analysts caution that the move may be more of a flow event than a fundamental catalyst. With shares trading well below their May high, the stock could be vulnerable if SpaceX volatility continues to pressure the sector or if investors view the Nasdaq-100 addition as already priced in. The key test will be whether Rocket Lab can sustain its growth trajectory and deliver on the Neutron program, which will determine whether the stock can regain its earlier highs.
